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Abstract
Background: There is a critical need for real-time tracking of behavioral indicators of mental disorders. Mobile sensing platforms
that objectively and noninvasively collect, store, and analyze behavioral indicators have not yet been clinically validated or
scalable.
Objective: The aim of our study was to report on models of clinical symptoms for post-traumatic stress disorder (PTSD) and
depression derived from a scalable mobile sensing platform.
Methods: A total of 73 participants (67% [49/73] male, 48% [35/73] non-Hispanic white, 33% [24/73] veteran status) who
reported at least one symptom of PTSD or depression completed a 12-week field trial. Behavioral indicators were collected
through the noninvasive mobile sensing platform on participants’ mobile phones. Clinical symptoms were measured through
validated clinical interviews with a licensed clinical social worker. A combination hypothesis and data-driven approach was used
to derive key features for modeling symptoms, including the sum of outgoing calls, count of unique numbers texted, absolute
distance traveled, dynamic variation of the voice, speaking rate, and voice quality. Participants also reported ease of use and data
sharing concerns.
Results: Behavioral indicators predicted clinically assessed symptoms of depression and PTSD (cross-validated area under the
curve [AUC] for depressed mood=.74, fatigue=.56, interest in activities=.75, and social connectedness=.83). Participants reported
comfort sharing individual data with physicians (Mean 3.08, SD 1.22), mental health providers (Mean 3.25, SD 1.39), and medical
researchers (Mean 3.03, SD 1.36).
Conclusions: Behavioral indicators passively collected through a mobile sensing platform predicted symptoms of depression
and PTSD. The use of mobile sensing platforms can provide clinically validated behavioral indicators in real time; however,
further validation of these models and this platform in large clinical samples is needed.
(J Med Internet Res 2017;19(3):e75)   doi:10.2196/jmir.6678
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Introduction
Exploring behavioral patterns has tremendous potential to aid
clinicians and patients in the real-time recognition and treatment
of symptoms and symptom clusters across a variety of disease
states. Early recognition of subsyndromal mood and anxiety
symptoms is crucial to reduce the pernicious impact of chronic
psychological distress and loss of function [1-3]. Yet many
affected individuals are unable to receive timely and adequate
mental health resources [4]. A key objective of the National
Institute of Mental Health’s strategic plan is to identify clinically
useful behavioral indicators to determine effective intervention
strategies and deliver those interventions at the appropriate time
in the illness trajectory [5].
Barriers exist to objectively identifying behaviors in real time.
Mobile sensing platforms allow for not only the collection of
these behavioral indicators, but also can provide the complex
architecture for securely storing, analyzing, and providing
feedback. More specifically, mobile sensing platforms can
enable the identification and tracking of behaviors (eg, mood,
fatigue, social connectedness, physical isolation) from digital
trace data passively collected from sensors embedded on mobile
devices (eg, call logs, global positioning system [GPS]
meta-data, phone activity) [6]. However, this approach still
needs to be clinically validated and shown to be scalable; the
application of mobile sensing platforms in clinical care is
currently limited. A National Institutes of Health (NIH) mHealth
evidence workshop cautioned that, despite the promise of these
new technologies in clinical care, theoretically based empirical
evidence is needed [7]. In this paper, we present a field trial of
the implementation of a mobile sensing platform to provide
clinically validated behavioral indicators of symptoms of
depression and PTSD.
Digital trace data has been used to track and predict behavioral
outcomes (eg, GPS data to predict friendship networks amongst
graduate students [8] and location and proximity data to predict
changes in an individual’s physical health [9]). Mobile sensing
platforms using mobile phone trace data have shown some
success in predicting self-reported depression [10,11]; however,
they have focused on diagnosis and not on tracking specific
symptoms.
In addition to digital trace data, the analysis of cues from the
voice as a behavioral indicator is another tremendous potential
of mobile sensing platforms. Vocal cues can provide valuable
insights into physical and mental states, not just through lexical
content but also through prosody, voice quality, and overall
tone of voice. Analysis of vocal cues can be useful for inferring
emotional states [12,13]; for example, various aspects of vocal
prosody have been linked to depression severity [14-16]. Vocal
cue analysis has recently been supported in a clinical use-case
for detecting and telemonitoring symptom progression in
Parkinson’s disease [17-19]. However, the potential of audio
processing has been largely understudied for clinical use cases
outside of Parkinson’s disease. Human experts can identify
changes in speech properties of depressed individuals [20] and
recent efforts have been made to quantify these vocal features
[21].
There is potential to complement or replace traditional methods
of assessing mental health and well-being that rely upon an
individual’s self-report (ie, surveys, questionnaires, diagnostic
interviews) with passively collected indicators derived from
behavioral indicators and vocal cues [22,23]. Clinicians would
not have to rely solely on subjective retrospective self-reports
of symptoms during clinical visits that are subject to recall and
other response biases or symptom tracking by self-report that
has low levels of sustained adherence.
Identifying and tracking behavioral indicators also has clinical
relevance beyond diagnosis. These behavioral indicators, even
if validated against a specific clinical symptom, can provide
information to clinicians across a number of chronic or comorbid
conditions. Patients can have complex profiles of symptoms
and underlying behavioral patterns that can be present in a
number of different conditions. The Research Domain Criteria
(RDoC) framework emphasizes the clinical value for considering
underlying behaviors and thinking across categories of mental
health disorders [24]. Having access to objectively measured
behavioral indicators can help subtype mood and anxiety
disorders and recognize patterns in individual patients.
The goal of this project was to test the ability of a scalable
mobile sensing platform to collect, store, and analyze objective
behavioral indicators underlying mood and anxiety disorder
symptoms. Specifically, we hypothesized that models of
behavioral indicators of PTSD and depression symptoms could
be derived from mobile-based digital trace data and auditory
signals.
Methods
Participants
Participants were recruited through Web-based advertisements
and local veteran service organizations. Inclusion criteria
included: age 18 years or older, English speaker, current
subscriber to a cellular and data plan, and if they reported at
least one symptom of PTSD or depression (measured by Primary
Care PTSD Screen, PC-PTSD [25] and the Patient Health
Questionnaire, PHQ-2 [26]). Participants were excluded if they
had plans to permanently leave the Boston area during the study
period, if they shared their cell phone with another person, or
if they were active duty military personnel. The protocol was
approved by an accredited institutional review board, and all
participants were consented. Additional participant and safety
details are included in the Multimedia Appendix 1.
Procedure
Each participant had an initial study visit, 12 weeks of data
gathering, and a follow-up study visit. At the initial visit,
participants completed a baseline questionnaire and replaced
their existing phone with the study mobile phone, equipped with
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the research app. At the time of the study, the app was limited
to a small number of devices so participants transferred their
cellular plan and all personal cell phone data to the study
Android device. The mobile app has since been made compatible
across devices.
The participant used the phone as usual during the study period.
In addition, participants were instructed to leave an audio diary
entry in the app at least weekly. The audio recordings were
designed to be short “voicemail” style entries about how
participants were feeling or how their days were going. At the
end of the 12-week period, participants returned to the study
site and completed a semistructured clinical interview with a
trained clinician. In addition, participants completed a close-out
survey, were debriefed, and the mobile app and all study data
were removed from the phone. Participants were paid US
$15/hour for study visits, a 1-time US $50 incentive for
completing at least 75% of all assessments, and given the option
of keeping the study phone (valued at US $300).
Mobile Sensing Platform Architecture
Digital trace data (Table 1) were collected on intermittent fixed
schedules from predefined, configured probes built into the
phone’s operating system. The mobile software data gathering
and analysis platform was developed by Cogito with funding
from the Defense Advance Research Project Agency (DARPA).
Details of the platform architecture are in the Multimedia
Appendix 1.
Table 1. Categories of digital trace data.
DescriptionCategory
The physical handling of the phone. The phone hardware includes an accelerometer and gyroscope. The gyroscope was
used to determine angle, velocity, direction, and acceleration of the phone. The accelerometer provided data on rate of rotation
on the X, Y, and Z axes.
Activity
How the user is interacting with others through the phone. Collected the time and deidentified descriptor (see privacy and
security section) of all outgoing and ingoing phone calls and SMS (short message service, SMS) text messages.
Social
Where the phone is physically located. Data are combined by the phone operating system from global positioning service
(GPS), mobile phone tower triangulation, and WiFi network locations. These data consist of time stamp, longitude, and
latitude readings. WiFi network names, WiFi access, usernames, or passwords were not collected.
Location
When the phone is being used. Data are timestamps of when the phone screen is turned on or activated and when it is turned
off. We did not record app usage, keystrokes, or any other measure of active use of the device.
Device interaction
Data describing the physical device. This included variables on phone make, model, battery status (% full), and phone oper-
ating system version. This data is used for quality assurance testing.
Device information
Digital recordings of audio-diaries were processed to extract measurements related to speaking, rate, prosody, intonation,
and voice quality. These measurements were computed on short-term overlapping frames and then aggregated (using de-
scriptive statistics) over the entire audio diary entry. The lexical content of the recordings was not analyzed.
Vocal cues
Data Privacy and Security
Participants’ data were protected by a NIH Certificate of
Confidentiality, and utilized best practice technical approaches
to protect identity. This included both the identity of the
participant and the identity of individuals in contact, and
communication log data. Encrypted, hashed, deidentified
descriptors were used to label all data. Details on the security
methodology and algorithms are in the Multimedia Appendix
1.
Measures
Main Outcomes
Clinical symptoms were measured through validated clinical
interviews with a trained clinician using the depression and
PTSD modules of the Structured Clinical Interview for Mental
Disorders (SCID) [27]. We focused our models on 4
behaviorally relevant symptoms (Depression A1—depressed
mood most of the day; Depression A2—diminished interest or
pleasure in all or most activities; Depression A6—fatigue or
loss of energy; and PTSD C2—avoids activities, places, people).
Digital Trace Data
Digital trace data collected on the mobile sensing platform fell
into 6 categories (Table 1). Details on the schedule and quantity
of digital trace data gathered are in the Multimedia Appendix
1.
Additional Measures
Participants reported age, race, current annual income,
employment, level of education, marital status, and veteran
status. At the end of the study participants also reported ease of
use, interest in future use, and their perception of data sharing
and privacy concerns for both personal and anonymized health
data. All questions were 1 (very unlikely) to 5 (very likely)
Likert questions. Survey instruments are in Multimedia
Appendix 1.
Analysis
The primary analysis goal was to develop models utilizing
digital trace data and audio recordings to predict the presence
of clinician-assessed psychiatric symptoms. A secondary goal
was to have a model whose inputs reflected types and quantities
of data that could be realistically gathered in real world clinical
environments with minimal participant burden. A third goal to
facilitate clinical utilization and acceptability by clinicians was
to develop models with a hypothesis-driven approach from data
sources which were clinically interpretable.
Three symptoms of depression and PTSD with strong behavioral
components were chosen a priori as target goals for model
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development from digital trace data (fatigue, interest in
activities, and social connectedness). One symptom of
depression (depressed mood) was chosen a priori as the target
goal for model development from audio data. For each symptom,
a binary target variable was defined to characterize the presence
or absence of the symptom. To best model clinically relevant
differences in symptomatology, we removed participants with
only subthreshold symptoms or with insufficient information
to determine symptom presence or absence.
Participant audio and mobile features were derived using the
most recent week of data (1 week of data prior to the SCID
symptom assessment). An initial modeling approach predicted
symptoms based on the entire 12-week data collection period;
however, high discrimination of the classes was achieved using
features temporally closer to the target assessment.
For the 3 models trained from digital trace data, we used the
following methodology. Through data exploration and a priori
hypotheses on how mobile phone data would capture relevant
behaviors, we created a set of features using descriptive statistics
over a week of digital trace data. These features included means,
counts, and standard deviations of social and location digital
trace data (number of texts received in a week, number of
minutes spent on outbound calls in the last week). Activity data
(see Table 1) was excluded after extensive data exploration
failed to yield conceptually meaningful features. Device
interaction data (see Table 1) was excluded as data exploration
determined that events were being captured for push
notifications, not just user-device interactions; therefore, the
interaction data did not accurately represent user behavior. The
set of features were further reduced by cluster analysis to
enhance interpretability on the resulting models and improve
prediction performance. The set of 14 features were reduced to
prevent over-fitting and interfeature correlation. Reduction
method consisted of identifying clusters of features such that
within group correlation is high with respect to between group
correlation, which highlighted 3 clusters that conceptually
matched a digital trace data source (location, social calls, social
texts). From each grouping, a single feature was chosen, that
conceptually matched a digital trace data source (location, social
calls, social texts). Combinations of features were utilized to
create 10 candidate models per symptom. Candidate models
consisted of logistic models describing the probability of having
the corresponding symptom. To select the best model from the
list of candidates, we utilized 10-fold cross validation. The
model with the highest cross-validated area under the ROC
curve (AUC) was chosen (Table 2).
Table 2. Model characteristics and performance.
Cross-validated
area under the
curve (AUC)
Input featuresSymptom target
.74MeanPitchVar+MeanVocalEffort+MeanVocalEffort:MeanPitchVarDepressed mood most of the day
.56sms.address.count+travel.distance.sumDiminished interest or pleasure in all or most activities
.75call.out.sum+sms.address.countFatigue or loss of energy
.83call.out.sum+sms.address.count+(call.out.sum)(sms.address.count)Avoid activities, places, people
One model was trained using audio data. The audio was sampled
at 8 kHz with 16-bit precision. M4A compression was applied
to audio captured by the device and the format was subsequently
converted to waveform audio file format (WAV) before
computing audio features. Candidate audio features to develop
this model were defined by an existing library of features
providing temporal information about voice quality, prosody,
and intonation. Audio features were aggregated over time as an
average and standard deviation per recording. A penalized
logistic regression approach, least absolute shrinkage and
selection operator (LASSO) [28], was used to reduce the initial
set of features using the depressed mood symptom target as the
dependent variable. The penalization parameter was determined
by 10-fold cross validation. Five candidate features remained
following this reduction strategy. Candidate models were created
in the same fashion as models created from digital trace data,
and the model with the highest cross-validated AUC following
10-fold cross-validation was selected.
Details on the set of reduced features for each model,
representative examples from the published literature which
include audio feature algorithms, and the full list of candidate
models are in the Multimedia Appendix 1.
Results
Participant Characteristics
Ninety-five participants consented to the study. One participant
called to withdraw and 21 were withdrawn due to technical
issues (most commonly a lost phone). Seventy-three participants
(67% male, 48% non-Hispanic white, 33% veterans) completed
all 12-weeks of data collection and a follow-up clinical interview
(see Multimedia Appendix 1 for detailed participant
characteristics). There was no difference between participants
who completed the study and those that did not in terms of
demographic characteristics. All participants reported a lifetime
history of at least one traumatic event during clinical interview.
The 12-week dataset included 1217 participant audio recordings
and 51,080,131 digital trace data points.
Models and Model Fit
The resulting models for each of the 4 dependent variable
modeling targets are in Table 2. See Figure 1 for receiver
operating characteristic (ROC) curves. Detailed model
performance, including positive and negative predictive values
and accuracy at varying thresholds, are included in the
Multimedia Appendix 1. At a .5 threshold, models predicted
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clinically assessed symptoms of depression and PTSD
(cross-validated AUCs for depressed mood .74, fatigue .56,
interest in activities .75, and social connectedness .83). No
information on prior diagnoses, current comorbidities, lifestyle,
or demographic characteristics was included in the models to
achieve these AUCs.
Figure 1. Receiver operating characteristic curves (ROC) and area under the curve (AUC).
Acceptability and Feasibility
Adherence to study protocol was extremely high with 96% of
participants (N=70) completing at least one audio diary per
week. Participants found the mobile app easy to use (Mean 4.05,
SD 1.14) and were interested in using the app in the future
(Mean 3.59, SD 1.27). Overall participants reported moderate
comfort with sharing individual data (Mean 2.48, SD 0.91) and
anonymized data (Mean 3.00, SD 1.23). There were no
significant differences by age, gender, or veteran status in
comfort with sharing. For individualized data, participants were
most comfortable with sharing their personal data with primary
care physicians (Mean 3.08, SD 1.22), mental health providers
(Mean 3.25, SD 1.39), and medical researchers (Mean 3.03, SD
1.36). Participants reported the least comfort with sharing
individualized data with insurance providers (Mean 1.63, SD
1.06) and friends (Mean 1.95, SD 1.12).
Discussion
Principal Findings
In this study, we examined the use of a mobile sensing platform
to passively collect and analyze digital trace and voice data as
behavioral indicators of clinically-validated symptoms of
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depression and PTSD. The models were predictive of
clinician-assessed symptoms of depressed mood, fatigue, interest
in activities, and social connectedness. This study highlights
the power of mobile sensing platforms to gather and compute
behavioral indicators of symptoms of mood and anxiety
disorders.
To have clinical relevance, modeling strategies for behavioral
indicators should be parsimonious (simple), objective (unbiased),
and actionable (useful in real-world clinical settings). The
modeling strategy in the present analysis was parsimonious,
distilling millions of raw data points into a small number of key
features. The models were objective, utilizing passively collected
digital trace data, and extracted vocal features of tonality and
speaking style. Adding self-reported predictors to the models
reported here did not significantly increase model performance.
There are established biases in self-reporting of mental states
[29]. Biases may be intentional or unintentional, as the disorders
themselves can change the way patients perceive their own
actions. Finally, the models were actionable. Predictive models
that have been developed for other disorders, including
suicidality, rely on social determinants and clinical
characteristics that have to be extracted from electronic medical
records [30]. Clinicians may want to know what is happening
with patients, but asking patients may not always yield accurate
results [31,32].
In addition, these behavioral indicators described by the models
are clinically meaningful. The models are based off of
clinician-assessed symptoms and not self-report instruments.
These models include behavioral indicators that can capture
clinically relevant levels of impairment. For example, the models
are not concerned with whether a patient walked 9000 steps
versus 10,000 steps, but if the patient has not left his house in
the past week. The models use macro level behavioral features
as inputs, such as distance traveled over a week, to predict
symptoms that both patients and clinicians can understand and
potentially intervene upon. The present models do not assume
a causal link between the behavioral indicators and clinical
symptoms; nevertheless, the models may be of interest to
clinicians and patients regardless of their causal pathways, as a
means to track and alert to changes in symptoms in real time.
These models are not designed to replace clinical
decision-making or diagnose a particular mental health
condition, but rather to assess a number of behavioral indicators
underlying mood and anxiety disorders. These models are a
resource to provide clinically relevant behavioral information
to augment clinical care.
This study also demonstrates the feasibility and scalability of
mobile sensing platforms for capturing, sharing, and analyzing
behavioral data. Participants reported comfort with sharing even
personal data with clinicians and medical researchers. They
were willing to use the app in the future and reported that it did
not change their behavior. Future research should continue to
explore feasibility and acceptability of mobile sensing platforms
in different populations and how this technology influences
patients, clinicians, and their interactions.
Clinical Relevance
The behavioral indicator algorithms created in this study, when
embedded within a high performance, highly scalable, cloud
computing architecture has distinct advantages in clinical care.
The models described in this study utilize only 1 week of data
to make predictions, and when implemented in high-performance
code can automatically provide new values on patient behavior
daily. Continuous monitoring can allow patients, clinicians, or
researchers to view changes and symptom trajectories over time.
Passive data collection does not burden patients and is free from
self-report subject to biases. Current mHealth approaches for
mental health assessment, including mobile phone apps and
ecological momentary assessment methods, may be an
improvement over paper and pencil measures, but still require
direct patient input [22,33] and many have not been clinically
validated [34]. The use of mobile sensing platforms could allow
clinicians and researchers to track episode onset, symptom
progression, and relapse across populations with less patient
burden [35]. Patients, caregivers, or clinicians could be alerted
to clinically meaningful changes in behavioral indicators
between clinical interactions.
Currently, there is no real-time, continuous, and objective
solution to collect, analyze, and track mental health
symptom-related behavioral indicators. The mobile sensing
approach validated in this study streamlined the process by
which clinically-relevant indicators are gathered and transmitted.
Each year, approximately 6.9% of all US adults experience
major depressive disorder [36] and PTSD prevalence is
estimated at 6.8% over a lifetime [37]. The rates of mood and
anxiety disorders are even higher among veterans. Although
estimates vary by study and service era, current prevalence of
depression in veterans of Iraq and Afghanistan conflicts is
estimated at 13.8% [38] and lifetime prevalence of PTSD is
estimated at 30.9% for male veterans and 26.9% for female
veterans [39]. This innovative mobile sensing platform offers
a scalable approach to care for millions with mood and anxiety
disorders.
This study sample is larger than in previous studies of mobile
sensing platforms and weighted to prevalence estimates;
however, it is a convenience sample from the community and,
subsequently, results may lack generalizability. Although the
study demonstrates proof of concept, additional validation of
these models is needed.
The use of this innovative approach could empower patient
health self-management. Recognizing warning signs and changes
in behavioral patterns can be difficult for patients with mood
and anxiety disorders, particularly those without easy access to
care or those experiencing symptoms near episode onset.
Disability and behavior are closely linked and mental disorders
represent a leading cause of disability. Developing approaches
to identify functional disability that do not rely on self-report
is an important extension to this work. Patients who are more
aware of their own behavioral patterns, particularly between or
before clinical appointments, maybe are better able to manage
their own health. A mobile sensing platform could be capable
of providing real-time feedback to patients and clinicians,
enabling increased help seeking behavior and access to needed
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care. Patients and providers can use behavioral data to recognize
more objectively and definitively when they need to seek
additional services. These additional novel metrics may enable
clinicians to provide better informed clinical care. The efficacy
of such a platform in improving clinical care remains to be
tested.
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